Table 3 Comparison of the functional scales and the tramadol usage at each evaluation time-point.
half term intervention group | full term intervention group | p-value | ||
|---|---|---|---|---|
Pre-interventional evaluation | WOMAC (0–96) | 40.86 ± 10.89 | 37.47 ± 12.71 | 0.544 |
6 minute walk test (meter) | 126.86 ± 64.05 | 146.59 ± 89.24 | 0.602 | |
Timed-stands test (second) | 24.71 ± 5.25 | 26.8 8 ± 7.11 | 0.534 | |
The first week | Number of tramadol weekly consumption | 3.00 ± 2.24 | 1.98 ± 1.53 | 0.288 |
WOMAC | 35.00 ± 15.01 | 30.41 ± 11.57 | 0.426 | |
6 minute walk test | 282.57 ± 132.19 | 220.77 ± 91.19 | 0.199 | |
Timed-stands test | 22.43 ± 5.86 | 22.57 ± 3.31 | 0.418 | |
The second week | Number of tramadol weekly consumption | 2.14 ± 2.41 | 1.33 ± 1.70 | 0.534 |
WOMAC | 19.14 ± 13.98 | 21.12 ± 9.74 | 0.695 | |
6 minute walk test | 337.71 ± 85.77 | 290.64 ± 80.26 | 0.213 | |
Timed-stands test | 19.71 ± 5.29 | 20.44 ± 2.96 | 0.400 | |
The fifth week | WOMAC | 10.86 ± 10.84 | 14.59 ± 9.14 | 0.398 |
6 minute walk test | 407.00 ± 83.62 | 353.35 ± 82.35 | 0.163 | |
Timed-stand test | 19.00 ± 6.16 | 19.29 ± 2.80 | 0.867 |
